Hikma Pharmaceuticals (HKMPF) Stock Chart & Stock Price History → “The Stock Market’s Bull Run is Far from Over” -Barrons (From Vertical Research Advisory) (Ad) Free HKMPF Stock Alerts $23.37 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort Interest Hikma Pharmaceuticals Stock Price Performance5 Day PerformanceN/A1 Month Performance-11.81%3 Month Performance+2.57%6 Month PerformanceN/AYear-To-Date Performance+2.57%1 Year Performance+13.23% Receive HKMPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… HKMPF Stock Chart for Friday, March, 29, 2024 HKMPF Chart by TradingView Hikma Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/27/2024$23.37$23.37$23.37$23.3770 shs$5.15 billion03/26/2024$23.37$23.37$23.37$23.373 shs$5.15 billion03/21/2024$23.37$23.37$23.37$23.37946 shs$5.15 billion03/08/2024$23.37$23.37$23.37$23.37166 shs$5.15 billion03/07/2024$24.32$23.37-3.91%$23.37$23.37166 shs$5.15 billion03/06/2024$24.32$24.32$24.32$24.32200 shs$5.36 billion Get the Latest News and Ratings for HKMPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/01/2024$26.50$24.32-8.23%$24.32$24.32200 shs$5.36 billion02/29/2024$26.50$26.50$26.50$26.503 shs$5.84 billion02/23/2024$26.50$26.50$26.50$26.001,104 shs$5.84 billion02/22/2024$25.00$26.50+6.00%$26.50$26.001,104 shs$5.84 billion02/19/2024$25.00$25.00$25.00$25.0072 shs$5.51 billion02/16/2024$25.00$25.00$25.00$25.00328 shs$5.51 billion02/15/2024$24.33$25.00+2.75%$25.00$25.00328 shs$5.51 billion02/14/2024$24.02$24.33+1.29%$24.33$24.33115 shs$5.36 billion02/09/2024$24.02$24.02$24.42$24.023,050 shs$5.29 billion02/08/2024$24.16$24.02-0.58%$24.42$24.023,050 shs$5.29 billion02/05/2024$24.16$24.16$24.16$24.1633 shs$5.32 billion01/31/2024$24.16$24.16$24.16$24.1640 shs$5.32 billion01/30/2024$24.16$24.16$24.16$24.16500 shs$5.32 billion01/29/2024$24.16$24.16$24.16$24.16500 shs$5.32 billion01/26/2024$24.53$24.16-1.49%$24.16$24.16500 shs$5.32 billion01/25/2024$24.53$24.53$24.53$24.53118 shs$5.40 billion01/22/2024$24.53$24.53$24.53$24.53100 shs$5.40 billion01/19/2024$24.73$24.53-0.83%$24.53$24.53118 shs$5.40 billion01/17/2024$24.66$24.73+0.28%$24.73$24.69400 shs$5.45 billion01/16/2024$24.66$24.66$24.66$24.66500 shs$5.43 billion01/15/2024$24.66$24.66$24.66$24.66500 shs$5.43 billion01/12/2024$23.50$24.66+4.94%$24.66$24.66500 shs$5.43 billion01/09/2024$23.50$23.50$23.50$23.50250 shs$5.18 billion01/08/2024$23.50$23.50$23.50$23.50250 shs$5.18 billion01/05/2024$23.50$23.50$23.50$23.50183 shs$5.18 billion01/04/2024$22.79$23.50+3.14%$23.50$23.50183 shs$5.18 billion01/02/2024$22.79$22.79$22.79$22.79500 shs$5.02 billion01/01/2024$22.79$22.79$22.79$22.79500 shs$5.02 billion12/29/2023$22.30$22.79+2.17%$22.79$22.79500 shs$5.02 billion12/28/2023$22.73$22.30-1.89%$22.30$22.301,136 shs$4.91 billion Related Companies: Zealand Pharma A/S Stock Price Chart Aspen Pharmacare Stock Price Chart Orion Oyj Stock Price Chart Amplifon Stock Price Chart GN Store Nord A/S Stock Price Chart Aurora Cannabis Stock Price Chart Sino Biopharmaceutical Stock Price Chart Nihon Kohden Stock Price Chart Sysmex Stock Price Chart Eurofins Scientific Stock Price Chart Receive HKMPF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:HKMPF) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.